Skip to main content


Fig. 3 | Cell & Bioscience

Fig. 3

From: miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients

Fig. 3

Kaplan–Meier analysis showing the PFS of adenocarcinoma and squamous carcinoma in patients with methylated NSCLC. (a) Representation of miR-7 methylation status among adenocarcinoma and squamous tumor histologic types, showing that the presence of methylation is more common in adenocarcinoma than in squamous tumor types. (b) Kaplan–Meier survival curve for PFS for TCGA early-stages NSCLC patients harboring miR-7 methylation (n = 523). 370 patients with adenocarcinoma and 153 squamous cell carcinoma. The PFS of patients with adenocarcinoma was significantly lower (p = 0.002)

Back to article page